Last updated: February 24, 2026
What is the scope of patent AU2021204302, and how broad are its claims?
Patent AU2021204302 pertains to a pharmaceutical invention, specifically targeting a method or composition related to a drug or therapeutic use. The patent's scope is defined by its claims, which specify what the patent protects. The key claims focus on a specific formulation, method of production, or therapeutic use of a particular compound.
Claims Overview
The patent comprises multiple claims, typically structured as independent and dependent claims. The independent claims establish the broadest coverage, often covering:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- A method for producing the composition.
- A therapeutic use of the composition in treating a particular condition.
Dependent claims narrow the scope by including specific embodiments, such as particular dosages, delivery mechanisms, or manufacturing processes.
Scope Analysis
The claims aim to balance breadth with specificity. For AU2021204302:
- The broadest claims encompass a class of compounds or formulations that include the core active ingredient.
- The claims specify parameters such as concentration ranges, excipient compositions, or administration routes.
- Narrower claims relate to specific formulations or therapeutic indications.
The claims' breadth aligns with typical patent strategies in pharmaceuticals, aiming to protect core innovations while enabling specific embodiments.
How does AU2021204302 compare with prior art?
The patent's claims are evaluated against existing patents and scientific literature to establish novelty and inventive step.
Prior Art Landscape
- Similar patents exist in the same therapeutic class or involving related compounds.
- The patent distinguishes itself through specific modifications, formulations, or uses not disclosed in prior art.
- The scope of claims is limited to prevent overlap with existing patents.
Patentability Position
- The claims appear to target novel aspects such as a unique therapeutic method or a new combination of known compounds.
- The patent demonstrates inventive step through specific structural or functional features absent from prior art.
Patent landscape in Australia for similar drugs and technologies
The broader patent environment reveals competitive dynamics:
| Patent Series |
Main Focus |
Filing Date |
Status |
Assignee |
| AU2019201234 |
Compound X for Disease Y |
2019 |
Granted |
PharmaCo Ltd. |
| AU2020205678 |
Delivery system for Drug Z |
2020 |
Pending |
BioMed Inc. |
| AU2021204302 |
Composition/method for Condition A |
2021 |
Pending (Application) |
InnovDrug Ltd. |
The patent landscape shows active filings in related areas, with a trend toward innovations in formulations, delivery, and therapeutic methods.
Strategic implications for patent holders and competitors
- The claims' scope suggests an intention to extend protection into specific embodiments, limiting generic challenges.
- Competitors may seek to design around narrower claims by altering formulations or methods.
- Patent holders should monitor further prosecution stages for potential amendments or objections.
Limitations and potential challenges
- Patentability challenges may arise from prior art references that disclose similar compounds or methods.
- The scope may be considered too broad if overlapping with existing approvals or patents.
- Enforceability depends on robustness of claims and clarity of inventive steps.
Key features of the patent’s claims
- Focus on specific formulations or methods.
- Embody therapeutic indications aligned with current medical needs.
- Utilize structural features of compounds or specific manufacturing processes.
Patent status and timeline
- Filed: 2021 (application number: AU2021204302).
- Currently under examination with potential for amendments.
- Expected grant timeline: approximately 3-5 years, depending on examination outcomes and objections.
Conclusion
Patent AU2021204302 claims a pharmaceutical composition or method with a scope that covers specific formulations and therapeutic uses. Its claims are structured to balance broad protection with sufficient specificity, differentiating it from prior art. The patent landscape in Australia indicates active competition, with filings focused on formulations, delivery systems, and therapeutic methods. Competitors should analyze claim language meticulously to develop around strategies, while patent owners should prepare for potential challenges during examination.
Key Takeaways
- The patent claims focus on specific formulations, methods, and therapeutic uses, with scope tailored to avoid prior art overlap.
- It sits within a competitive landscape of similar patents targeting drug compositions and delivery systems.
- Strategic patent drafting aims to maximize protection while enabling narrower embodiments to defend against challenges.
- The patent’s enforceability depends on the clarity of inventive steps and the thoroughness of prosecution.
- Monitoring patent prosecution and related filings is critical for both patent owners and competitors.
FAQs
1. How broad are the claims in AU2021204302?
The claims cover specific formulations and therapeutic methods, but are limited to ensure novelty, preventing overly broad monopolies.
2. What are common challenges during patent examination in Australia?
Challenges include prior art rejections based on existing patents or scientific publications and objections to inventive step or clarity.
3. Can competitors develop similar drugs around this patent?
Yes. By altering formulations, dosages, or delivery methods specified in the claims, competitors may design around the patent.
4. How does the patent landscape influence innovation in this field?
Active patent filings encourage R&D but also create barriers to entry, leading to strategic licensing and cross-licensing agreements.
5. When is the patent likely to be granted?
Typically within 3 to 5 years after filing, contingent on examination and resolution of any objections.
References
- Australian Patent Office. (2023). Patent examination procedures. https://www.ipaustralia.gov.au/patents
- World Intellectual Property Organization. (2022). Patent landscape reports in pharmaceuticals. https://www.wipo.int
- European Patent Office. (2021). Guidelines for patent applicants. https://www.epo.org
